Salary range:
£31,604 - £38,833
FTE:
1 (35 hours/week)
Term:
Fixed (2 years)
Closing date:
05/11/2017
Applications are invited for Post-doctoral Research positions at grade 7 at the EPSRC Future Manufacturing Research Hub in Continuous Manufacturing and Advanced Crystallisation (www.cmac.ac.uk): a national research centre led by the University of Strathclyde. It comprises a multidisciplinary team of academics and researchers located across seven Universities within the UK. The Hub provides a platform for collaborative research, training and knowledge exchange in the area of advanced pharmaceutical manufacturing with a vibrant programme of basic and applied research that spans advanced processing of active ingredients and formulated systems, process analysis, modelling, monitoring and control and product analysis, testing and characterisation.
As part of our programme, we now have a number of exciting opportunities for researchers to work on cutting edge industry demand-led projects. The posts involve applying and translating the research learning in CMAC to real-life industrial challenges, so excellent verbal and written communication skills are essential.
You will have a PhD in a relevant subject (Pharmaceutical Sciences, Chemistry, Chemical Engineering, software engineering/modelling or related discipline) with appropriate experience in process development, crystallisation, isolation, formulation, modelling and control as well as collaborative research programmes; ideally with industrial experience.
This is an exciting and challenging position which will provide an ambitious and committed candidate with the opportunity to broaden their research within a multi-disciplinary, multi-site environment working on industry collaborative projects to deliver real impact. The positions will be initially for 12 months and it is expected there will be the opportunity of extension if the candidate performs well.
CMAC has recently benefited from significant capital investments to create a world class suite of research facilities. CMAC houses a comprehensive suite of high-value, state-of-the-art continuous processing equipment, novel monitoring and control systems, modelling and control software and extensive off-line characterisation capabilities. The Hub has a large and vibrant programme with key Industry partners, AZ, Bayer, GSK, Lilly, Novartis, Roche and Takeda with a broad range of technology companies and SMEs.
Informal enquiries about the post can be directed to Dr Ian Houson, Technical Project Manager (0141 548
4507 / ian.houson@strath.ac.uk).
Click here for full details